Summary & Overview
HCPCS G9549: Documentation for Follow-Up Diagnostic Imaging
HCPCS Level II code G9549 denotes documentation that a medical reason exists for follow-up diagnostic imaging — for example, lymphadenopathy, suspected metastasis, or an active or prior cancer diagnosis. Nationally, the code matters because it clarifies clinical justification for additional imaging when routine surveillance criteria are exceeded, supporting appropriate utilization and claims review in oncology-related and diagnostic imaging pathways.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise review of what the code represents, payer coverage context, and the clinical situations where documentation of follow-up imaging is typically asserted. The publication outlines benchmarks and reimbursement context where available, recent policy considerations affecting documentation requirements, and clinical scenarios that commonly prompt use of the code. Practical guidance on where the service is typically provided and the types of clinical justification tied to the code are included. Data not available in the input is noted where payer-specific rates, associated taxonomies, and ICD-10 mappings would normally appear.
Billing Code Overview
HCPCS Level II code G9549 documents that a medical reason exists to perform follow-up imaging, such as lymphadenopathy, signs of metastasis, an active diagnosis or history of cancer, or other clinical indications. The code supports documentation that imaging beyond routine care is medically indicated based on the patient’s condition.
-
Service type: Follow-up imaging documentation and medical justification
-
Typical site of service: Radiology departments, outpatient imaging centers, hospital outpatient departments, and other clinical settings where diagnostic imaging is ordered
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of treated breast cancer presents to the oncology clinic for routine surveillance. During the clinic visit the patient reports new cervical lymph node enlargement on self-exam and recent unintentional weight loss. The treating oncologist documents an active history of malignancy, focal lymphadenopathy on exam, and a clinical concern for possible metastatic disease. The clinician records the specific medical reasons that follow-up imaging (such as diagnostic CT, PET/CT, or ultrasound) is indicated to evaluate the lymphadenopathy and assess for recurrence or metastasis.
Clinical workflow: The oncologist documents the medical rationale in the medical record and places an order for targeted imaging. The documentation includes the active cancer diagnosis or history of cancer, focal signs (e.g., palpable lymphadenopathy), change in symptoms or physical findings, and the urgency or timing for imaging. This documentation supports use of billing code G9549 to indicate medical necessity for follow-up imaging. Imaging is scheduled at an appropriate ambulatory imaging center or hospital radiology department and results are returned to the ordering clinician for management decisions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | When documentation supports substantially greater work than typical for associated services (e.g., extensive additional documentation of complex clinical rationale for imaging) |